Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer.

MLA

Cruz, Vitor Alves, et al. “Safety of CoronaVac and ChAdOx1 Vaccines against SARS-CoV-2 in Patients with Rheumatoid Arthritis: Data from the Brazilian Multicentric Study Safer.” Advances in Rheumatology (London, England), vol. 64, no. 1, Aug. 2024, p. 58. EBSCOhost, https://doi.org/10.1186/s42358-024-00397-5.

APA

Cruz, V. A., Guimarães, C., Rêgo, J., Machado, K. L. L. L., Miyamoto, S. T., Burian, A. P. N., Dias, L. H., Pretti, F. Z., Batista, D. C. F. A., Mill, J. G., de Oliveira, Y. G. P., Gadelha, C. S. E., da Penha Gomes Gouveia, M., Moulin, A. C. S., Souza, B. O., Aguiar, L. G. R., Vieira, G. S. S., Grillo, L. L., de Lima, M. D., … da Silva, N. A. (2024). Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer. Advances in Rheumatology (London, England), 64(1), 58. https://doi.org/10.1186/s42358-024-00397-5

Chicago

Cruz, Vitor Alves, Camila Guimarães, Jozelia Rêgo, Ketty Lysie Libardi Lira Machado, Samira Tatiyama Miyamoto, Ana Paula Neves Burian, Laiza Hombre Dias, et al. 2024. “Safety of CoronaVac and ChAdOx1 Vaccines against SARS-CoV-2 in Patients with Rheumatoid Arthritis: Data from the Brazilian Multicentric Study Safer.” Advances in Rheumatology (London, England) 64 (1): 58. doi:10.1186/s42358-024-00397-5.